Technical Analysis for PLXP - PLx Pharma Inc.
| ADX | Long-Term | Intermediate-Term | Short-Term |
|---|---|---|---|
| Strong | Up | Up | Up |
| See historical PLXP trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Mar 18 | Pocket Pivot | Bullish Swing Setup | 0.00% |
| Mar 18 | Upper Bollinger Band Walk | Strength | 0.00% |
| Mar 18 | Inside Day | Range Contraction | 0.00% |
| Mar 18 | Above Upper BB | Strength | 0.00% |
| Mar 18 | Up 3 Days in a Row | Strength | 0.00% |
| Mar 18 | Up 4 Days in a Row | Strength | 0.00% |
| Mar 18 | Upper Bollinger Band Touch | Strength | 0.00% |
| Mar 15 | Pocket Pivot | Bullish Swing Setup | 0.51% |
| Mar 15 | Stochastic Reached Overbought | Strength | 0.51% |
| Mar 15 | Upper Bollinger Band Walk | Strength | 0.51% |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 2019-03-08
- Sector: Healthcare
- Industry: Bio Therapeutic Drugs
PLx Pharma Inc., formerly Dipexium Pharmaceuticals, Inc., is a biopharmaceutical company. The Company is a late stage specialty pharmaceutical company focusing on commercializing its lead products: Aspertec 325 mg and Aspertec 81 mg (Aspertec). The Company’s products and technology includes PLxGuard delivery system, Aspertec 325 mg, PL1100/PL1200 Ibuprofen. PLxGuard delivery system uses surface acting lipids, such as phospholipids and free fatty acids, to modify the physiochemical properties of various drugs to selectively release these drugs to targeted portions of the GI tract. The Company’s lead product Aspertec 325 mg is a liquid-fill aspirin capsule for prevention of cardiovascular disease. Through PLxGuard delivery system the Company creates a lipid-based formulation of ibuprofen, PL1200 Ibuprofen Capsules, 200 mg.
Biopharmaceutical Drugs Organic Compounds Cardiovascular Disease Analgesics Hepatotoxins Carboxylic Acids Ibuprofen
Biopharmaceutical Drugs Organic Compounds Cardiovascular Disease Analgesics Hepatotoxins Carboxylic Acids Ibuprofen
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength | |||
| Summary: | Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies. | ||
See more PLXP news...
Indicators
| Indicator | Value |
|---|---|
| 52 Week High | 6.6 |
| 52 Week Low | 1.0 |
| Average Volume | 42,605 |
| 200-Day Moving Average | 4.0183 |
| 50-Day Moving Average | 4.8695 |
| 20-Day Moving Average | 5.1396 |
| 10-Day Moving Average | 5.4103 |
| Average True Range | 0.4967 |
| ADX | 28.26 |
| +DI | 23.4017 |
| -DI | 11.693 |
| Chandelier Exit (Long, 3 ATRs ) | 4.7499 |
| Chandelier Exit (Short, 3 ATRs ) | 5.5501 |
| Upper Bollinger Band | 5.8937 |
| Lower Bollinger Band | 4.3855 |
| Percent B (%b) | 1.03 |
| BandWidth | 29.344696 |
| MACD Line | 0.2537 |
| MACD Signal Line | 0.1773 |
| MACD Histogram | 0.0764 |
| Fundamentals | Value |
|---|---|
| Market Cap | 51.61 Million |
| Num Shares | 8.69 Million |
| EPS | -1.03 |
| Price-to-Earnings (P/E) Ratio | -5.77 |
| Price-to-Sales | 196.43 |
| Price-to-Book | 5.02 |
| PEG Ratio | -0.13 |
| Dividend | 0.00 |
| Dividend Yield | 0.00% |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 6.56 | ||||
| Resistance 3 (R3) | 6.54 | 6.32 | 6.45 | ||
| Resistance 2 (R2) | 6.32 | 6.16 | 6.33 | 6.42 | |
| Resistance 1 (R1) | 6.13 | 6.07 | 6.23 | 6.15 | 6.38 |
| Pivot Point | 5.91 | 5.91 | 5.96 | 5.92 | 5.91 |
| Support 1 (S1) | 5.72 | 5.75 | 5.82 | 5.74 | 5.50 |
| Support 2 (S2) | 5.50 | 5.66 | 5.51 | 5.46 | |
| Support 3 (S3) | 5.31 | 5.50 | 5.43 | ||
| Support 4 (S4) | 5.33 |
